Alyeska Investment Group’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,437
| Closed | -$354K | – | 413 |
|
|
2019
Q4 | $354K | Buy |
+1,437
| New | +$354K | ﹤0.01% | 337 |
|
|
2018
Q2 | – | Sell |
-13,957
| Closed | -$3.93M | – | 462 |
|
|
2018
Q1 | $3.93M | Sell |
13,957
-171
| -1% | -$48.2K | 0.03% | 285 |
|
|
2017
Q4 | $3.32M | Hold |
14,128
| – | – | 0.03% | 264 |
|
|
2017
Q3 | $4.01M | Buy |
14,128
+252
| +2% | +$71.5K | 0.03% | 288 |
|
|
2017
Q2 | $3.91M | Buy |
13,876
+6,568
| +90% | +$1.85M | 0.03% | 283 |
|
|
2017
Q1 | $2.44M | Sell |
7,308
-6,410
| -47% | -$2.14M | 0.02% | 368 |
|
|
2016
Q4 | $4.53M | Buy |
13,718
+110
| +0.8% | +$36.3K | 0.04% | 322 |
|
|
2016
Q3 | $3.64M | Buy |
13,608
+7,709
| +131% | +$2.06M | 0.03% | 335 |
|
|
2016
Q2 | $781K | Buy |
5,899
+120
| +2% | +$15.9K | 0.01% | 388 |
|
|
2016
Q1 | $1.02M | Buy |
5,779
+1,379
| +31% | +$243K | 0.01% | 349 |
|
|
2015
Q4 | $1.1M | Buy |
4,400
+179
| +4% | +$44.7K | 0.01% | 330 |
|
|
2015
Q3 | $1.19M | Sell |
4,221
-697
| -14% | -$196K | 0.01% | 369 |
|
|
2015
Q2 | $683K | Buy |
4,918
+79
| +2% | +$11K | 0.01% | 411 |
|
|
2015
Q1 | $796K | Sell |
4,839
-255
| -5% | -$41.9K | 0.01% | 419 |
|
|
2014
Q4 | $764K | Sell |
5,094
-188
| -4% | -$28.2K | 0.01% | 397 |
|
|
2014
Q3 | $704K | Sell |
5,282
-250
| -5% | -$33.3K | 0.01% | 329 |
|
|
2014
Q2 | $1.04M | Buy |
5,532
+517
| +10% | +$97.5K | 0.02% | 313 |
|
|
2014
Q1 | $1.28M | Buy |
+5,015
| New | +$1.28M | 0.04% | 235 |
|